Cited by 260Liver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseaseDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Hepatic Steatosis: A Mediator of the Metabolic Syndrome. Lessons From Animal Models

den Boer, M., Voshol, P.J., Kuipers, F., Havekes, L.M., Romijn, J.A.·2004·Arteriosclerosis, Thrombosis, and Vascular Biology

DOI 10.1161/01.atv.0000116217.57583.6e

Open this paper in CoChat — free account

Abstract

Epidemiological studies in humans, as well as experimental studies in animal models, have shown an association between visceral obesity and dyslipidemia, insulin resistance, and type 2 diabetes mellitus. Recently, attention has been focused on the excessive accumulation of triglycerides (TG) in the liver as part of this syndrome. In this review, important principles of the pathophysiological involvement of the liver in the metabolic syndrome obtained in rodent models are summarized. We focus on non-alcoholic causes of steatosis, because the animal experiments we refer to did not include alcohol as an experimental condition. In general, there is continuous cycling and redistribution of non-oxidized fatty acids between different organs. The amount of TG in an intrinsically normal liver is not fixed but can readily be increased by nutritional, metabolic, and endocrine interactions involving TG/free fatty acid (FFA) partitioning and TG/FFA metabolism. Several lines of evidence indicate that hepatic TG accumulation is also a causative factor involved in hepatic insulin resistance. Complex interactions between endocrine, metabolic, and transcriptional pathways are involved in TG-induced hepatic insulin resistance. Therefore, the liver participates passively and actively in the metabolic derangements of the metabolic syndrome. We speculate that similar mechanisms may also be involved in human pathophysiology.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.atv.0000116217.57583.6e

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ
Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884
The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years.
Powell, E. E., Cooksley, G. W. E., Hanson, R., Searle, J., Halliday, J. W., & Powell, L. W. (1990) · Hepatology · doi:10.1002/hep.1840110114 · Cited by 1,473
Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.
Wanless, I. R., & Lentz, J. S. (1990) · Hepatology · doi:10.1002/hep.1840120505 · Cited by 1,191
Nonalcoholic steatohepatitis: An expanded clinical entity
Bacon, B. R., Farahvash, M. J., Janney, C. G., & Neuschwander‐Tetri, B. A. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90235-6 · Cited by 1,137
Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling
SHEPHERD, P. R., WITHERS, D. J., & SIDDLE, K. (1998) · Biochemical Journal · doi:10.1042/bj3330471 · Cited by 953
Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.
Vidal‐Puig, A., Considine, R. V., Jimenez‐Liñan, M., Werman, A., Pories, W. J., Caro, J. F., & Flier, J. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119424 · Cited by 785
Defective Uptake and Utilization of Long Chain Fatty Acids in Muscle and Adipose Tissues of CD36 Knockout Mice
Coburn, C. T., Knapp, F. F., Febbraio, M., Beets, A. L., Silverstein, R. L., & Abumrad, N. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003826200 · Cited by 726
Increased Levels of Nuclear SREBP-1c Associated with Fatty Livers in Two Mouse Models of Diabetes Mellitus
Shimomura, I., Bashmakov, Y. K., & Horton, J. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.30028 · Cited by 704
Regulation of Plasma Cholesterol by Lipoprotein Receptors
Brown, M. S., Kovanen, P. T., & Goldstein, J. L. (1981) · Science · doi:10.1126/science.6261329 · Cited by 702
Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice
Gavrilova, O., Marcus-Samuels, B., Graham, D., Kim, J. K., Shulman, G. I., Castle, A. L., Vinson, C., Eckhaus, M., & Reitman, M. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7901 · Cited by 676
Molecular Mechanisms Regulating Hormone-Sensitive Lipase and Lipolysis
Holm, C., Østerlund, T., Laurell, H., & Contreras, J. A. (2000) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.20.1.365 · Cited by 572
Nonalcoholic steatohepatitis: A study of 49 patients
Lee, R. G. (1989) · Human Pathology · doi:10.1016/0046-8177(89)90249-9 · Cited by 547
Stimulation of Lipogenesis by Pharmacological Activation of the Liver X Receptor Leads to Production of Large, Triglyceride-rich Very Low Density Lipoprotein Particles
Grefhorst, A., Elzinga, B. M., Voshol, P. J., Plösch, T., Kok, T., Bloks, V. W., van der Sluijs, F. H., Havekes, L. M., Romijn, J. A., Verkade, H. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204887200 · Cited by 505
Self-citation
The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver diseasePowell EE, Cooksley WGE, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years [Hepatology 1990; 11:74–80]
Caldwell, S. H., & Crespo, D. M. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.02.013 · Cited by 499
Defect in Peroxisome Proliferator-activated Receptor α-inducible Fatty Acid Oxidation Determines the Severity of Hepatic Steatosis in Response to Fasting
Hashimoto, T., Cook, W. S., Qi, C., Yeldandi, A. V., Reddy, J. K., & Rao, M. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910350199 · Cited by 450
Animal Models of Steatosis
Koteish, A. A., & Diehl, A. M. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12932 · Cited by 447
Peroxisome Proliferator—Activated Receptor (PPAR)-αActivation Lowers Muscle Lipids and Improves Insulin Sensitivity in High Fat—Fed Rats
Ye, J., Doyle, P. J., Iglesias, M. A., Watson, D. G., Cooney, G. J., & Kraegen, E. W. (2001) · Diabetes · doi:10.2337/diabetes.50.2.411 · Cited by 343
Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study.
Fujimoto, W. Y., Bergstrom, R. W., Boyko, E. J., Chen, K. W., Leonetti, D. L., Newell-Morris, L., Shofer, J. B., & Wahl, P. W. (1999) · Diabetes Care · doi:10.2337/diacare.22.11.1808 · Cited by 296
Insulin- and Mitogen-activated Protein Kinase-mediated Phosphorylation and Activation of Peroxisome Proliferator-activated Receptor γ
Zhang, B., Berger, J. P., Zhou, G., Elbrecht, A., Biswas, S., White-Carrington, S., Szalkowski, D., & Moller, D. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.31771 · Cited by 276
FATTY LIVER: A STUDY OF 270 PATIENTS WITH BIOPSY PROVEN FATTY LIVER AND A REVIEW OF THE LITERATURE
Leevy, C. M. (1962) · Medicine · doi:10.1097/00005792-196209000-00003 · Cited by 272
Insulin effects on sterol regulatory-element-binding protein-1c (SREBP-1c) transcriptional activity in rat hepatocytes
Azzout‐Marniche, D., Bécard, D., Guichard, C., Foretz, M., Ferré, P., & Foufelle, F. (2000) · Biochemical Journal · doi:10.1042/bj3500389 · Cited by 270
Liporegulation in Diet-induced Obesity
Lee, Y., Wang, M.-Y., Kakuma, T., Wang, Z.-W., Babcock, E. E., McCorkle, K., Higa, M., Zhou, Y.-T., & Unger, R. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008553200 · Cited by 269
Transgenic Overexpression of Leptin Rescues Insulin Resistance and Diabetes in a Mouse Model of Lipoatrophic Diabetes
Ebihara, K., Ogawa, Y., Masuzaki, H., Shintani, M., Miyanaga, F., Aizawa‐Abe, M., Hayashi, T., Hosoda, K., Inoue, G., Yoshimasa, Y., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.6.1440 · Cited by 240
PPARα deficiency reduces insulin resistance and atherosclerosis in apoE-null mice
Tordjman, K. M., Bernal‐Mizrachi, C., Zemany, L., Weng, S., Chu, F., Zhang, F., Leone, T. C., Coleman, T., Kelly, D. P., & Semenkovich, C. F. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11497 · Cited by 228
Acute Effects of Insulin in the Control of VLDL Production in Humans: Implications for the insulin-resistant state
Lewis, G. F., & Steiner, G. A. (1996) · Diabetes Care · doi:10.2337/diacare.19.4.390 · Cited by 226
Adipose tissue hormones
Guerre-Millo, M. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03344048 · Cited by 215
Hepatic metabolism of free fatty acids in normal and diabetic dogs
Basso, L. V., & Havel, R. J. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106264 · Cited by 203
Peroxisome Proliferator–Activated Receptor-α Agonist Treatment in a Transgenic Model of Type 2 Diabetes Reverses the Lipotoxic State and Improves Glucose Homeostasis
Kim, H., Haluzı́k, M., Shyr, Z. A., Yau, D., Joseph, J. W., Fernandez, A. M., Reitman, M. L., Yakar, S., STANNARD, B. S., Héron‐Milhavet, L., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1770 · Cited by 192
CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice
Goudriaan, J. R., Dahlmans, V. E. H., Teusink, B., Ouwens, D. M., Febbraio, M., Maassen, J. A., Romijn, J. A., Havekes, L. M., & Voshol, P. J. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300143-jlr200 · Cited by 191
Self-citation
Inhibition of Microsomal Triglyceride Transfer Protein: Another Mechanism for Drug–Induced Steatosis in Mice
Lettéron, P., Sutton, A., Mansouri, A., Fromenty, B., & Pessayre, D. (2003) · Hepatology · doi:10.1053/jhep.2003.50309 · Cited by 189
Tissue-specific regulation of lipoprotein lipase activity by insulin/glucose in normal-weight humans
Farese, R. V., Yost, T. J., & Eckel, R. H. (1991) · Metabolism · doi:10.1016/0026-0495(91)90178-y · Cited by 179
Association of Multiple Risk Factors and Insulin Resistance With Increased Prevalence of Asymptomatic Coronary Artery Disease by an Electron-Beam Computed Tomographic Study
Arad, Y., Newstein, D., Cadet, F., Roth, M., & Guerci, A. D. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1201.100257 · Cited by 172
Fat Accumulation in the Liver Is Associated with Defects in Insulin Suppression of Glucose Production and Serum Free Fatty Acids Independent of Obesity in Normal Men
Seppala-Lindroos, A. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3023 · Cited by 168
Concurrent exercise prevents high-fat-diet-induced macrovesicular hepatic steatosis
Gauthier, M., Couturier, K., Latour, J.-G., & Lavoie, J.-M. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01164.2002 · Cited by 167
De novo lipogenesis during controlled overfeeding with sucrose or glucose in lean and obese women
McDevitt, R. M., Bott, S. J., Harding, M., Coward, W. A., Bluck, L. J., & Prentice, A. M. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.6.737 · Cited by 166
Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance
Laakso, M., & Lehto, S. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00314-6 · Cited by 161
Increased Hepatic Insulin Sensitivity Together with Decreased Hepatic Triglyceride Stores in Hormone-Sensitive Lipase-Deficient Mice
Voshol, P. J., Haemmerle, G., Ouwens, D. M., Zimmermann, R., Zechner, R., Teusink, B., Maassen, J. A., Havekes, L. M., & Romijn, J. A. (2003) · Endocrinology · doi:10.1210/en.2002-0036 · Cited by 125
Self-citation
In Muscle-Specific Lipoprotein Lipase−Overexpressing Mice, Muscle Triglyceride Content Is Increased Without Inhibition of Insulin-Stimulated Whole-Body and Muscle-Specific Glucose Uptake
Voshol, P. J., Jong, M. C., Dahlmans, V. E. H., Kratky, D., Levak‐Frank, S., Zechner, R., Romijn, J. A., & Havekes, L. M. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2585 · Cited by 119
Self-citation
Toxicological consequences of altered peroxisome proliferator-activated receptor γ (PPARγ) expression in the liver: insights from models of obesity and type 2 diabetes11Abbreviations: PPAR, peroxisome proliferator-activated receptor; 15d-PGJ2, 15-deoxy-Δ12,14-prostaglandin J2; NEFA, non-esterified fatty acid; T2DM, type 2 (non-insulin-dependent) diabetes mellitus; LPS, lipopolysaccharide; NSAIDs, nonsteroidal anti-inflammatory drugs; IL, interleukin; TNF α, tumor necrosis factor-α; TRAIL, tumor necrosis factor-related apoptosis-inducing ligand; and TZD, thiazolidinedione.
Boelsterli, U. A., & Bedoucha, M. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00817-6 · Cited by 103
Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
Rubinstein, A., Gibson, J. C., Paterniti, J. R., Kakis, G., Little, A., Ginsberg, H. N., & Brown, W. V. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111751 · Cited by 83
Mechanisms of metabolic dyslipidemia in insulin resistant states deregulation of hepatic and intestinal lipoprotein secretion
Adeli, K. (2003) · Frontiers in bioscience · doi:10.2741/1022 · Cited by 70
Acute Inhibition of Glucose-6-Phosphate Translocator Activity Leads to Increased De Novo Lipogenesis and Development of Hepatic Steatosis Without Affecting VLDL Production in Rats
Bandsma, R., Wiegman, C., Herling, A. W., Burger, H.-J., ter Harmsel, A., Meijer, A. J., Romijn, J. A., Reijngoud, D., & Kuipers, F. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2591 · Cited by 70
Self-citation
Preperitoneal fat deposition estimated by ultrasonography in patients with non-insulin-dependent diabetes mellitus
Tayama, K., Inukai, T., & Shimomura, Y. (1999) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(98)00118-1 · Cited by 46
Obesity in db and ob animals leads to impaired hepatic very low density lipoprotein secretion and differential secretion of apolipoprotein B-48 and B-100
Li, X., Grundy, S. M., & Patel, S. B. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37412-5 · Cited by 45
Effects of leptin on adipose tissue lipoprotein lipase in the obese ob/ob mouse
Picard, F., Richard, D., Huang, Q., & Deshaies, Y. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800732 · Cited by 32
Hepatic steatosis in rats fed diets with varying concentrations of sucrose
Bacon, B. R. (1984) · Fundamental and Applied Toxicology · doi:10.1016/0272-0590(84)90104-0 · Cited by 27
Insulin-regulated transcription factors: molecular link between insulin resistance and cardiovascular risk factors
Müller‐Wieland, D., Knebel, B., Avci, H., Lehr, S., Laudes, M., Ristow, M., Krone, W., & Kotzka, J. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801694 · Cited by 16

Research works printed but not linked: 3

10.1161/atvb.21.12.2051 · DOI
10.1210/jcem.87.7.8638 · DOI · Paper page
2001, Int J Obes Relat Metab Disord, 25, S35

Sorted by citations

Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites†
Neuschwander‐Tetri, B. A. (2010) · Hepatology · doi:10.1002/hep.23719 · Cited by 1,077
Triglyceride Metabolism in the Liver
Alves‐Bezerra, M., & Cohen, D. E. (2017) · Comprehensive physiology · doi:10.1002/cphy.c170012 · Cited by 1,324
Fructose, insulin resistance, and metabolic dyslipidemia
Basciano, H., Federico, L. M., & Adeli, K. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-5 · Cited by 858
Defining high-fat-diet rat models: Metabolic and molecular effects of different fat types
Buettner, R., Parhofer, K. G., Woenckhaus, M., Wrede, C. E., Kunz-Schughart, L. A., Schölmerich, J., & Bollheimer, L. C. (2006) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01909 · Cited by 704
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554

See all 260

Authors: den Boer, M., Voshol, P. J., Kuipers, F., Havekes, L. M., & Romijn, J. A.
Affiliations: From TNO Prevention and Health (M.d.B., P.J.V., L.M.H.), Gaubius Laboratory Leiden, Leiden, The Netherlands; Department of Endocrinology and Diabetes (M.d.B., P.J.V., J.A.R.), Department of General Internal Medicine (L.M.H.), and Department of Cardiology (L.M.H.), Leiden University Medical Center, Leiden, The Netherlands; and Center for Liver, Digestive, and Metabolic Diseases (F.K.), Department of Pediatrics, University Hospital Groningen, Groningen, The Netherlands.
Leiden University (NL)
ORCID: Voshol, P.J.
Kuipers, F.
Romijn, J.A.
Venue: Arteriosclerosis, Thrombosis, and Vascular Biology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2004-04
Volume: 24
Issue: 4
Pages: 644-649
ISSN: 1079-5642 (ISSN-L)
1524-4636
DOI: 10.1161/01.atv.0000116217.57583.6e
OpenAlex: W2160518844
Cited by: 260
References: 49
Citations by year: 2026: 1 · 2025: 4 · 2024: 3 · 2023: 5 · 2022: 3 · 2021: 5 · 2020: 5 · 2019: 7 · 2018: 7 · 2017: 13 · 2016: 15 · 2015: 17 · 2014: 5 · 2013: 6 · 2012: 16
FWCI: 3.67
Type: journal article
Language: en
Open access: closed
Locations: Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
PubMed (publishedVersion)
Pure Amsterdam UMC (publishedVersion)
University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion)
TNO Repository (submittedVersion)
Repository hosted by TU Delft Library (TU Delft) (submittedVersion)
University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
Funders: Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: hepatic steatosis, metabolic syndrome, non-alcoholic fatty liver disease, triglyceride accumulation, hepatic insulin resistance, visceral obesity, dyslipidemia, type 2 diabetes, rodent models
MeSH terms: Adipose Tissue, Animals, Diabetes Mellitus, Type 2, Dogs, Fatty Acids, Fatty Liver, Glucose, Homeostasis, Humans, Hyperlipidemias, Insulin Resistance, Liver, Models, Biological, Obesity, Rats, Zucker, Transcription, Genetic, Triglycerides, Models, Animal, Metabolic Syndrome, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hepatic Steatosis: A Mediator of the Metabolic Syndrome. Lessons From Animal Models

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks